{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T11:41:54Z","timestamp":1781869314192,"version":"3.54.5"},"reference-count":108,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T00:00:00Z","timestamp":1546732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R13CA232383\u201001"],"award-info":[{"award-number":["1R13CA232383\u201001"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R13CA232383\u201001"],"award-info":[{"award-number":["1R13CA232383\u201001"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000902","name":"Pediatric Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Patients with relapsed, refractory or advanced stage B non\u2010Hodgkin\u00a0lymphoma (<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content>) continue to\u00a0have a dismal prognosis. This review summarises current and novel cellular and\u00a0immunotherapy for these high\u2010risk populations, including haematopoietic stem cell transplant, bispecific antibodies, viral\u2010derived cytotoxic T cells, chimeric antigen receptor (<jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content>) T cells, and natural killer (<jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content>) cell therapy, as discussed at the 6th International Symposium on Childhood, Adolescent and Young Adult Non\u2010Hodgkin Lymphoma on September 26th\u201329th 2018 in Rotterdam, the Netherlands, and explores the future of <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CAR NK<\/jats:styled-content> therapies.<\/jats:p>","DOI":"10.1111\/bjh.15753","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T06:26:24Z","timestamp":1546842384000},"page":"1055-1070","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Advances in cellular and humoral immunotherapy \u2013 implications for the treatment of poor risk childhood, adolescent, and young adult B\u2010cell non\u2010Hodgkin lymphoma"],"prefix":"10.1111","volume":"185","author":[{"given":"Yaya","family":"Chu","sequence":"first","affiliation":[{"name":"Department of Pediatrics New York Medical College Valhalla NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Gardenswartz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics New York Medical College Valhalla NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Termuhlen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics University of Minnesota Medical School Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-434X","authenticated-orcid":false,"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics New York Medical College Valhalla NY USA"},{"name":"Department of Medicine New York Medical College Valhalla NY USA"},{"name":"Department of Pathology New York Medical College Valhalla NY USA"},{"name":"Department of Microbiology &amp; Immunology New York Medical College Valhalla NY USA"},{"name":"Department of Cell Biology &amp; Anatomy New York Medical College Valhalla NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,6]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7505"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.29245\/2578-3009\/2018\/1.1111"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1469-8"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13764"},{"issue":"1","key":"e_1_2_12_6_1","first-page":"67","article-title":"Blinatumomab significantly enhanced cytotoxicity and T\u2010cell cytokine secretion against Burkitt lymphoma (BL) and primary mediastinal B\u2010cell lymphoma (PMBL)","volume":"182","author":"Awasthi A.","year":"2018","journal-title":"British Journal of Haematology"},{"issue":"1","key":"e_1_2_12_7_1","first-page":"65","article-title":"Obinutuzumab significantly enhanced ADCC and improves overall survival in CD20+ primary mediastinal B\u2010cell lymphoma (PMBL) xenograft NSG mouse model","volume":"182","author":"Awasthi A.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0455"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14078"},{"issue":"1","key":"e_1_2_12_10_1","first-page":"48","article-title":"Phase 2 trial of obinutuzumab, a humanized glycoengineered monoclonal CD20 antibody, in combination with ifosfamide, carboplatin and etoposide for relapsed\/refractory mature B\u2010cell non\u2010Hodgkin lymphoma","volume":"182","author":"Barth M.J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694356"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.9.3179"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2012.111"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.5304"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.3179"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705948"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.128"},{"key":"e_1_2_12_18_1","first-page":"353","article-title":"Bone marrow transplantation in 46 pediatric patients with non\u2010Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children","volume":"15","author":"Bureo E.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_12_19_1","first-page":"24","article-title":"Role of HST in children and adolescents with refractory or relapsed NHL","volume":"182","author":"Burkhardt B.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036665"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.3369"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.10.003"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15491"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.23.3918"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-771832"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802845"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.05.016"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83092"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.91"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.038"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738245"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0114"},{"issue":"1","key":"e_1_2_12_33_1","first-page":"57","article-title":"Regulation of cytokine release and anti\u2010tumor effect of anti\u2010CD20 CAR modified expanded natural killer cells by ALT\u2010803, an IL\u201015 superagonist","volume":"182","author":"Chu Y.","year":"2018","journal-title":"British Journal of Haematology"},{"issue":"1","key":"e_1_2_12_34_1","first-page":"46","article-title":"2B8T2M, a novel fusion of ALT\u2010803, an IL\u201015 superagonist, with 4 single\u2010chains of anti\u2010CD20 antibody significantly ehanced expanded natural killer cells cytotoxicity against rituximab sensitive and resistant Burkitt lymphoma (BL)","volume":"182","author":"Chu Y.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.03.013"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1590"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214561"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0426"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701596"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3684-7_28"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441"},{"issue":"1","key":"e_1_2_12_42_1","first-page":"23","article-title":"Safety and efficacy of myeloablative conditioning autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed\/refractory mature B\u2010cell non Hodgkin lymphoma","volume":"182","author":"Gardenswartz A.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-422709"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2018.03.005"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4258"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24722"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.1586"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.255"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.09.021"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.09.028"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.07.002"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-1182"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-239186"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.03.014"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.3.649.649"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.121434"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2390"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384388"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-519413"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2025"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3024"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2015.02.008"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.8.2921"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07316.x"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1483"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.733600"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.020"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2098"},{"key":"e_1_2_12_70_1","first-page":"465","article-title":"High\u2010dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non\u2010Hodgkin's lymphoma","volume":"8","author":"Loiseau H.A.","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.24.021605.090727"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.9585"},{"issue":"1","key":"e_1_2_12_74_1","first-page":"21","article-title":"CD19\/CMV CAR T cells and post CMV vaccine strategies CMV\u2010CD19 BI\u2010specific CAR T cells and post\u2010infusion CMV vaccine strategies","volume":"182","author":"Nakamura R.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.73"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.7.1118"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxp047"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86000"},{"issue":"1","key":"e_1_2_12_80_1","first-page":"23","article-title":"Early response data for pediatric patients with non\u2010Hodgkin lymphoma treated with CD19 chimeric antigen receptor (CAR) T\u2010cells","volume":"182","author":"Rivers J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524155113"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-823757"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068440"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-785840"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.194"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46110"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2139"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2011.09.004"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4597"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1368"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-128843"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf8621"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-741058"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651380"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13051"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198687"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0009"},{"key":"e_1_2_12_99_1","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-1-36"},{"key":"e_1_2_12_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.10.002"},{"key":"e_1_2_12_101_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2920"},{"key":"e_1_2_12_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-686725"},{"key":"e_1_2_12_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06004.x"},{"key":"e_1_2_12_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0169-2"},{"key":"e_1_2_12_105_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2357"},{"key":"e_1_2_12_106_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002965"},{"key":"e_1_2_12_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2016.2"},{"key":"e_1_2_12_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2016.07.011"},{"key":"e_1_2_12_109_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901244"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.15753","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15753","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.15753","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T21:25:50Z","timestamp":1694381150000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.15753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,6]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/bjh.15753"],"URL":"https:\/\/doi.org\/10.1111\/bjh.15753","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,6]]},"assertion":[{"value":"2019-01-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}